ORIGINAL RESEARCH
Accepted on 31 Mar 2025
Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma
doi 10.3389/fphar.2025.1571786
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Combination Therapies in Cancer Treatment: Enhancing Efficacy and Reducing Resistance
Combination Therapies in Cancer Treatment: Enhancing Efficacy and Reducing Resistance
3,011
Total downloads
11k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 27 Mar 2025
Enhancing survival outcomes in unresectable hepatocellular carcinoma: a prospective cohort study on the effects of Huaier granules with targeted therapy plus immunotherapy
doi 10.3389/fphar.2025.1529010
- 308 views
ORIGINAL RESEARCH
Published on 25 Mar 2025
Milciclib-mediated CDK2 inhibition to boost radiotherapy sensitivity in colorectal cancer
doi 10.3389/fphar.2025.1557925
- 353 views
ORIGINAL RESEARCH
Published on 24 Mar 2025
Efficacy and safety of PD-1/PD-L1 inhibitors combined with tyrosine kinase inhibitors as first-line treatment for hepatocellular carcinoma: a meta-analysis and trial sequential analysis of randomized controlled trials
doi 10.3389/fphar.2025.1535444
- 449 views
REVIEW
Published on 10 Mar 2025
TCR-T cell therapy for solid tumors: challenges and emerging solutions
doi 10.3389/fphar.2025.1493346
- 730 views
MINI REVIEW
Published on 21 Feb 2025
Antibody-drug conjugate combinations in cancer treatment: clinical efficacy and clinical study perspectives
doi 10.3389/fphar.2025.1556245
- 1,124 views
SYSTEMATIC REVIEW
Published on 06 Dec 2024
Efficacy and safety of TACE combined with traditional Chinese medicine versus TACE alone in hepatocellular carcinoma: bayesian network meta-analysis and pharmacological mechanisms study
doi 10.3389/fphar.2024.1495343
- 947 views
ORIGINAL RESEARCH
Published on 11 Nov 2024
Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles
doi 10.3389/fphar.2024.1487940
- 510 views
- 2 citations
REVIEW
Published on 20 Sep 2024
Advancing cancer therapy: new frontiers in targeting DNA damage response
doi 10.3389/fphar.2024.1474337
- 3,004 views
- 2 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: